Drug Testing Locations - De Land, FL

Drug Testing in De Land, FL

De Land, Florida Statistics

De Land, located in Volusia County, FL, reported a notable rise in opioid-related overdoses by 15% from 2018 to 2020.

In De Land, Volusia County, FL, there were 345 drug-related arrests in 2019, marking a 10% increase from the previous year.

Volusia County health officials in De Land identified marijuana as the most commonly abused drug among teens in 2021.

The Volusia County Sheriff's Office in De Land, FL, seized over 1,000 grams of methamphetamine in multiple busts in 2020.

In 2022, De Land, Volusia County, FL, saw a reduction in cocaine-related incidents by 8%, as reported in local crime data.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in De Land, FL & Drug Testing Policies

In De Land, FL, employers are increasingly implementing drug testing policies to ensure a safe and productive work environment. Many organizations follow guidelines established by the U.S. Department of Labor, which advocates for workplaces free of substance abuse.

Local businesses in De Land often conduct pre-employment drug screenings as well as random tests for current employees. Policies align with state regulations, and employers may utilize resources from the Florida Department of Economic Opportunity to maintain compliance and support employees struggling with addiction.

Government Efforts with Drug Problems in De Land, FL

The government of De Land, FL, within Volusia County, has been actively addressing drug issues through various programs. Local authorities collaborate with the Volusia County Government to implement outreach initiatives focused on education and prevention.

State-level efforts are supported by the Florida Department of Health, which provides resources and support to combat drug abuse in communities like De Land. Federal agencies, including the DEA, partner with local law enforcement to address drug trafficking and distribution.

Local Drug Busts & News in De Land, FL

In recent months, De Land, FL has seen a series of drug busts targeting local distribution networks. The police have intensified efforts following community reports of increased drug activity. In one major operation, several individuals were arrested, and significant quantities of narcotics were confiscated, reflecting a larger trend of crackdowns within the county.

The community's vigilance played a crucial role, as tips from residents have often led to these successful operations. Collaborations between local law enforcement and federal agencies have proven instrumental in dismantling these operations. Regular town hall meetings aim to involve the community in proactive measures against illegal drug activities.

Efforts are not only limited to law enforcement. Various educational initiatives have been launched to raise awareness about the dangers of drug abuse. Schools in the area are participating in programs designed to educate young individuals about the risks and consequences, aiming to curb substance abuse.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in De Land, FL. Trusted by employers nationwide for accurate results and exceptional service.

Florida DOT/Non DOT Physicals

Florida Vision Tests

Florida Audiograms

Florida Respirator Fit Tests

Florida Lift Tests

Florida Background Checks

Clinical Testing Services

TB Testing in FL

Diabetes Testing in FL

Infectious Disease Testing in FL

Sickle Cell Anemia Testing in FL

Women/Men's Health Testing in FL

Resources & Citations

Substance Abuse and Mental Health Services Administration (SAMHSA)

Florida Alcohol & Drug Abuse Association (FADAA)

Florida Department of Children and Families Substance Abuse and Mental Health

Volusia-Flagler Coalition for the Homeless

Florida Department of Health

Drug Enforcement Administration (DEA)

National Institute on Drug Abuse (NIDA)

The Recovery Village

Drug Testing Near De Land, FL

Lake Mack-Forest Hills, FL

De Leon Springs, FL

Cassadaga, FL

Crows Bluff, FL

Orange City, FL

Lake Helen, FL

West DeLand, FL

West De Land, FL

De Land Southwest, FL

North De Land, FL

North DeLand, FL

DeLand, FL

Frequently Asked Questions

Customer Reviews